Anima

Alken 34 trials 15 recruiting

34 Registered trials

15 Currently recruiting

Organisation

Anima

Location

Alken, Belgium

Identifier

ORG-100047480

Address

Wetenschapspark 11-13, 3590, Belgium

Departments

Anima
ANIMA RESEARCH CENTER
ANIMA Research Loc. 1
BE001: Anima Research Center
General practicioner
General Practitioner
N/A
NA
Pneumology
Psychiatrie
Psychiatry
Research Center
Sleep Department

Clinical trials at this site (34)

Search interface

A Randomized, Double-blind, Multicenter, Placebo-controlled Study of Adjunctive Aticaprant Plus an Antidepressant for Relapse Prevention in … Ended

2024-511057-22-00 Major Depressive Disorder (MDD) with Moderate-to-severe 5 2024-12-04
A Randomized, Double-blind, Multicenter, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Aticaprant 10 mg as … Ended

2024-511557-21-00 Major Depressive Disorder (MDD) with Moderate-to-severe 5 2024-11-14
A clinical study of the V540A vaccine in healthy adults (V540A-001) Ended

2024-515785-14-00 Human Papilloma virus 1 2024-10-22
A Study to Evaluate the Efficacy and Safety of TAK-861 for the Treatment of Narcolepsy with Cataplexy Ended

2024-511998-30-00 Narcolepsy with Cataplexy (Narcolepsy Type 1) 5 2024-10-18
A Study to Investigate the Safety, Efficacy, and Immunogenicity of mRNA-1010 Candidate Influenza Vaccine Compared with a Licensed Influenza … Ended

2024-516240-26-00 Influenza 5 2024-10-11
A study to test different doses of BI 1569912 in people with depression who take anti-depressive medicine Ended

2023-507942-10-00 Major depressive disorder 4 2024-07-31
A study to learn about how elinzanetant works and how safe it is in women having sleep disturbances associated with menopause Ended

2023-504955-28-01 Sleep disturbances associated with menopause 4 2024-03-14
Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Ended

2024-512554-15-00 COVID-19 5 2023-06-21
A study to evaluate if aticaprant added to a current antidepressant and given up to one year is safe and would help improve depression. Ended

2023-508163-74-00 Major Depressive Disorder 5 2023-06-12
Assessment of the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's … Ended

2023-504991-31-00 Agitation in Patients With Dementia of the Alzheimer's 5 2021-05-06